888 related articles for article (PubMed ID: 17566692)
21. An alternative technique for totally implantable central venous access devices. A retrospective study of 1311 cases.
Chang HM; Hsieh CB; Hsieh HF; Chen TW; Chen CJ; Chan DC; Yu JC; Liu YC; Shen KL
Eur J Surg Oncol; 2006 Feb; 32(1):90-3. PubMed ID: 16289481
[TBL] [Abstract][Full Text] [Related]
22. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
[TBL] [Abstract][Full Text] [Related]
23. Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases.
Groebli Y; Wutrich P; Safa M; Tschantz P; Callewaert G; Piguet D
Panminerva Med; 1999 Jun; 41(2):89-92. PubMed ID: 10479903
[TBL] [Abstract][Full Text] [Related]
24. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.
Di Carlo I; Pulvirenti E; Mannino M; Toro A
Ann Surg Oncol; 2010 Jun; 17(6):1649-56. PubMed ID: 20204533
[TBL] [Abstract][Full Text] [Related]
25. Tunneled internal jugular catheters in adult patients: comparison of outcomes in hemodialysis versus infusion catheters.
Peynircioglu B; Ozkan F; Canyigit M; Cil BE; Balkanci F
Acta Radiol; 2007 Jul; 48(6):613-9. PubMed ID: 17611867
[TBL] [Abstract][Full Text] [Related]
26. Acute complications of central line placement in profoundly thrombocytopenic cancer patients.
Barrera R; Mina B; Huang Y; Groeger JS
Cancer; 1996 Nov; 78(9):2025-30. PubMed ID: 8964028
[TBL] [Abstract][Full Text] [Related]
27. The timing and sequence of multiple device-related complications in patients with long-term indwelling Groshong catheters.
Tolar B; Gould JR
Cancer; 1996 Sep; 78(6):1308-13. PubMed ID: 8826955
[TBL] [Abstract][Full Text] [Related]
28. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
Goossens GA; Stas M; Moons P
Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
[TBL] [Abstract][Full Text] [Related]
29. Totally implantable femoral vein catheters in cancer patients.
Wolosker N; Yazbek G; Munia MA; Zerati AE; Langer M; Nishinari K
Eur J Surg Oncol; 2004 Sep; 30(7):771-5. PubMed ID: 15296992
[TBL] [Abstract][Full Text] [Related]
30. Thrombosis of the superior vena cava and auxiliary branches in patients with indwelling catheterization of the internal jugular vein.
Li H; Wang SX; Wang W; Xu C; Shen S; Yu L; Zhang GZ
Chin Med J (Engl); 2009 Mar; 122(6):692-6. PubMed ID: 19323936
[TBL] [Abstract][Full Text] [Related]
31. Malposition of central venous catheters. Incidence, management and preventive practices.
Muhm M; Sunder-Plassmann G; Apsner R; Pernerstorfer T; Rajek A; Lassnigg A; Prokesch R; Derfler K; Druml W
Wien Klin Wochenschr; 1997 Jun; 109(11):400-5. PubMed ID: 9226858
[TBL] [Abstract][Full Text] [Related]
32. Prospective randomised study of cephalic vein cut-down versus subclavian vein puncture technique in the implantation of subcutaneous venous access devices.
D'Angelo FA; Ramacciato G; Aurello P; De Angelis R; Amodio P; Magrì M; Barillari P
Chir Ital; 2002; 54(4):495-500. PubMed ID: 12239758
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of three different techniques for insertion of totally implantable venous access device: A randomized clinical trial.
Tagliari AP; Staub FL; Guimarães JR; Migliavacca A; Mossmann Dda F
J Surg Oncol; 2015 Jul; 112(1):56-9. PubMed ID: 26175279
[TBL] [Abstract][Full Text] [Related]
34. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
[TBL] [Abstract][Full Text] [Related]
35. Central venous catheter placement at the time of extracorporeal membrane oxygenation decannulation: is it safe?
Rauth TP; Scott BP; Thomason CK; Bartilson RE; Hann TM; Pietsch JB
J Pediatr Surg; 2008 Jan; 43(1):53-7; discussion 58. PubMed ID: 18206455
[TBL] [Abstract][Full Text] [Related]
36. Morbidity after insertion of totally implantable venous access ports in oncological patients: results of a retrospective clinical study.
Aspalter M; Lechner M; Linni K; Hitzl W; Hölzenbein T; Ofner D; Emmanuel K
Am Surg; 2014 Feb; 80(2):204-7. PubMed ID: 24480224
[No Abstract] [Full Text] [Related]
37. Guidewire assisted cephalic vein cutdown for insertion of totally implantable access ports.
Chang HM; Hsieh HF; Hsu SD; Liao GS; Lin CH; Hsieh CB; Yu JC
J Surg Oncol; 2007 Feb; 95(2):156-7. PubMed ID: 17262733
[TBL] [Abstract][Full Text] [Related]
38. A complication associated with central line removal in the pediatric population: retained fixed catheter fragments.
Jones SA; Giacomantonio M
J Pediatr Surg; 2003 Apr; 38(4):594-6. PubMed ID: 12677573
[TBL] [Abstract][Full Text] [Related]
39. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
Wilson GJ; van Noesel MM; Hop WC; van de Ven C
J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
[TBL] [Abstract][Full Text] [Related]
40. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial.
Biffi R; Orsi F; Pozzi S; Pace U; Bonomo G; Monfardini L; Della Vigna P; Rotmensz N; Radice D; Zampino MG; Fazio N; de Braud F; Andreoni B; Goldhirsch A
Ann Oncol; 2009 May; 20(5):935-40. PubMed ID: 19179550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
